Navigation Links
Heartburn Sufferers Find Lasting Relief With TUMS(R) Dual Action
Date:4/8/2009

One tablet goes to work in seconds to relieve heartburn all day or all night

PITTSBURGH, April 8 /PRNewswire/ -- Approximately 60 million Americans experience heartburn at least once a month. For those sufferers whose occasional heartburn gets in the way of life, TUMS(R), the best selling antacid in America, is introducing a new, long-lasting treatment. TUMS Dual Action, just like all TUMS, goes to work in seconds but also lasts for hours -- all day or all night -- offering heartburn sufferers long-lasting relief without compromise.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090408/NY96327)

TUMS Dual Action contains calcium carbonate, the same trusted ingredient as the regular TUMS that Americans have depended upon for the past 75 years. TUMS Dual Action also includes an additional antacid ingredient, magnesium hydroxide, and 10 mg of famotidine, a safe and effective acid reducer, to help keep heartburn from coming back, making it the longest lasting TUMS ever. Available in Berry or Mint flavor, the one-dose chewable tablet immediately neutralizes acid on contact. Like all TUMS, it is also an excellent source of calcium, with 320 mg of elemental calcium per tablet.

"TUMS Dual Action is a natural extension for the iconic TUMS brand, offering a proven solution for occasional heartburn sufferers looking for long-lasting relief from a trusted source," says Jack Levy, TUMS Brand Manager at GlaxoSmithKline Consumer Healthcare. "With it, heartburn sufferers won't need to think about whether or not lunchtime heartburn will interrupt dinner, or whether they'll be able to sleep without being bothered by heartburn."

A Perfect Partner when Heartburn Breaks Through

In addition to providi
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack
2. Plavix Plus Heartburn Drugs May Hike Heart Risk
3. CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied
4. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
5. First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers
6. AUDIO from Medialink and Prilosec OTC: Recipes for Heartburn-Friendly Super Bowl Snacking
7. FDA Confirms No Heart Risk From Heartburn Drugs
8. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
9. Heartburn Can Be a Sign of Serious Disease
10. Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
11. Actress and Mom Alison Sweeney Teams Up With the American Pharmacists Association to Help Fellow Allergy Sufferers Find Relief This Spring

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (... will report financial results for the third quart...ay, November 9, 2009. Cardiome will hold a telecon... Pacific) on that day to discuss the results. ,, T...7806 or 888-789-9572 and reference conference 2345...
(Date:11/6/2009)... & Lymphoma Society (LLS) will again be partic...h in its first two campaigns this past spring and ...LS,s blood cancer research funding and patient edu...n, taking place from November 12th to 15th, Gap In... participants can use (in-store only) at all Gap ...
(Date:11/6/2009)... urgent message to the U.S. House of Representativ... in debate over procedures related to abortion and...eting to discuss proposed amendments to the bill, ... permit discussion of "an amendment to keep in pla...science protections." Some in the House seek a "cl...
(Date:11/6/2009)...rganizations specializing in infectious diseases p... expressing their significant concern with current...rotective equipment (PPE) by healthcare workers in...1 influenza. The Society for Healthcare Epidemio...ciety of America (IDSA) and the Association for Pr...
(Date:11/6/2009)...o by, researcher says , , FRIDAY, Nov. 6 (...le with multiple sclerosis who have relapses withi...kely to suffer from severe limitations in the shor...ngs, published Nov. 4 in Neurology , show that pe...s of developing it are nearly 50 percent more like...
Breaking Medicine News(10 mins):Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2
...th Staphylococcal,HIV, Tuberculosis and Other Infe...pitalized,patients for drug-resistant infections c...educe cost of care, according to a new report rele...,physicians to adjust medications or take other st...
...rgest Hope Lodge in,New York City, NEW YORK, Marc...enges. Finding an affordable, supportive place to ...ancer Society is pleased to,announce its newest an...t., the Hope Lodge,in Manhattan meets an urgent, p...
...r shamans and herb women? Not at all, for many che...cine are natural products or were developed on the...n prostate and breast cancer treatment are made fr... example, against malignant lymphomas. The modern ...
...on Against This Leading Cause...ording to the national,nonprofit, Home Safety Coun...use of home injury death in the United States. Yet...home safety concern,proving the need for aggressiv...
...hairman and Chief Executive Officer of Met-Pro Cor...pany,s Systems Division has received an,order to s... to a major,pharmaceutical company in the Northeas...the Company,s current fiscal,year., Working with ...
...ol? You may want to schedule a few appointments wi...e about how to shape up your eating habits, accord...ichigan Health System researchers. , Not only ar...e already taking one. And youll probably lose weig...
Other Medicine News:Health News:Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs 2Health News:American Cancer Society to Open Doors to Its New Free Lodging and Support Center in NYC for Cancer Patients and Caregivers 2Health News:Screening the herbal pharmacy 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 2Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 3Health News:New Home Safety Council(R) Research Shows the Majority of Families Underestimate the Danger of Poisoning Exposure at Home 4Health News:Met-Pro Corporation's Systems Division Receives Equipment Order Totaling Approximately $600,000 2Health News:Met-Pro Corporation's Systems Division Receives Equipment Order Totaling Approximately $600,000 3Health News:Study shows cholesterol-lowering power of dietitian visits 2Health News:Study shows cholesterol-lowering power of dietitian visits 3Health News:Study shows cholesterol-lowering power of dietitian visits 4
(Date:11/6/2009)...ewswire/ -- NexBio Inc., in collaboration with sci...vention (CDC), St. Louis University, and the Unive...n of two articles in the peer-reviewed journal PLo...AS181 (Fludase ® ) may play a potentially imp...e Pandemic Influenza A(H1N1) and drug-resistant in...
(Date:11/5/2009)...5 Osteotech, Inc. (Nasda...ogic products for regenerative healing, today repo... September 30, 2009. ,, "During the third quart...ree new biologic products MagniFuse(TM) Bone Graf...74; Innovative Grafting," said Sam Owusu-Akyaw, Pr...
(Date:11/5/2009)...PRNewswire/ -- ARKRAY, Inc., the world,s 5th large...s, today announced that it has received 510(k) cle...r its new GLUCOCARD Vital blood glucose monitoring...hich ARKRAY will make available for distribution i...complement to the existing GLUCOCARD line of produ...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 1Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 2Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 3Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 4Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 1Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 2Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime Anywhere Access to Patient Data and Communications 55393 3Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 1Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 2Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 3Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA 28TM 29 in the U S 55388 4
... FOR RELEASE AT 5 P.M. EDT MONDAY, AUG. 4/, /ADVA...r should not be,screened for prostate cancer, and ...of the prostate-specific antigen (PSA) test with t...a new recommendation from the U.S.,Preventive Serv...ng,evidence summary appear in the August 5 issue o...
...nts achieved SVR 12 with 48-week boceprevir-based ... High SVR 24 rate also reported for 28-week bocepr...gh,Corporation (NYSE: SGP ) today reported top-li...ase II study of boceprevir, its investigational,or...owed a high rate of,sustained virologic response (...
Other Medicine Technology:Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 2Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
...lectrophysiology imaging have become more acute. ...iation exposure to both patient and staff has beco...ne systems. In keeping with Omegas goal of mainta...ionship, four bi-plane imaging configurations are ...
...our office efficiency by reducing errors and elimi...ive cardiology software solution, you can spend le...nd more time on your patient care. Cardiology soft...ith over 50,000 installations and a long track rec...
...eSuite, is a Web Browser-based Ambulatory software...t, Electronic Medical Record (EMR) and Managed Car...rys demand for dependable HIPAA-era management sof...centric software products and services that provid...
...Healthcare Systems offers Misys Tiger, our compreh...tion that helps you run your practice more efficie...screens, online help and custom views harness Misy...more physicians are relying on this practice manag...
Medicine Products: